Learn More
Bio X Cell Anti-Human PD-1, Nivolumab Biosimilar, IgG4, 1 MG
Supplier: Bio X Cell SIM0003R001MG
This non-therapeutic biosimilar antibody utilizes the same variable regions as the therapeutic antibody Nivolumab, making it suitable for research applications. It is reactive with human PD-1 (programmed death-1), also identified as CD279. This humanized IgG4 monoclonal antibody is engineered with a hinge mutation (S228P) to minimize non-specific binding and enhance stability.
- Clone: Nivolumab
- Reactivity: Human
- Isotype: Human IgG4
- Mutations: S228P
- Formulation: PBS, pH 7.0 (no stabilizers/preservatives)
- Purity: ≥95% (SDS-PAGE)
- Production: Animal-free facility
- Purification: Protein A
- Endotoxin: ≤0.5 EU/mg
- Aggregation: <5%
- Sterility: 0.2 μm filtration
- Molecular weight: 150 kDa
- Storage: 4°C (do not freeze)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.